[Inflammatory pathologies of the rhinosinusitis: rationale for the use of anti-inflammatory agents].
Bellussi
L
L
Istituto di Discipline Otorinolaringologiche, Università degli Studi di Siena.
D000893:Anti-Inflammatory Agents / Q000145:classification / Q000627:therapeutic use*; D016207:Cytokines / Q000276:immunology; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D009297:Nasal Mucosa / Q000276:immunology / Q000473:pathology; D012220:Rhinitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D012852:Sinusitis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D007073:Immunoglobulin E